Hansoh Pharma

September 11, 2019

Atomwise Announces Largest China-US Collaboration for AI Drug Discovery

Press Release

Atomwise could receive up to US$1.5 billion to develop first in-class and best in-class small molecules through partnership with China’s leading biopharmaceutical company, Hansoh Pharma.

Read Article